People with Alzheimer’s Disease (AD) gradually lose the ability to control attention and develop impairments of a gaze-shift toward a prominent stimulus, as well away from this stimulus. A noteworthy question is whether eye-movement impairments are detectable in people who are in a preclinical stage of AD and therefore at a greater risk of developing clinical dementia. Read More